LBA Wealth Management »

Contravir Pharma shares owned by LBA Wealth Management

Quarter-by-quarter ownership of Contravir Pharma shares owned by LBA Wealth Management from 13F filings

Historical chart of LBA Wealth Management investment in Contravir Pharma

Tip: Access up to 7 years of quarterly data

All positions including Contravir Pharma held by LBA Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contravir Pharma by LBA Wealth Management

Quarter filed Position value Share count Share price at filing
2017-03-31 $14k 8.0k 1.75
2016-09-30 $15k 14k 1.07
2016-06-30 $15k 14k 1.07
2016-03-31 $15k 12k 1.25

More positions owned by LBA Wealth Management

Vanguard Total Bond Market ETF (BND)
SPDR S&P MidCap 400 ETF (MDY)
Vanguard Short Term Corporate Bond ETF (VCSH)
iShares S&P MidCap 400 Index (IJH)
Vanguard Emerging Markets ETF (VWO)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
Nuveen Barclays Shrt Term Muni bdfund (SHM)
iShares Lehman Aggregate Bond (AGG)
iShares MSCI EAFE Index Fund (EFA)
Apple (AAPL)
iShares S&P 500 Index (IVV)
Spdr S&p 500 Etf (SPY)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)

View all positions for LBA Wealth Management